These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
359 related articles for article (PubMed ID: 25331008)
1. Radical surgery with total mesorectal excision in patients with T1 rectal cancer. Kulu Y; Müller-Stich BP; Bruckner T; Gehrig T; Büchler MW; Bergmann F; Ulrich A Ann Surg Oncol; 2015; 22(6):2051-8. PubMed ID: 25331008 [TBL] [Abstract][Full Text] [Related]
2. [Total excision of the mesorectum in cancer of the lower and middle rectum. Oncological and functional results]. Kneist W; Heintz A; Wolf HK; Junginger T Chirurg; 2003 Feb; 74(2):125-31. PubMed ID: 12599030 [TBL] [Abstract][Full Text] [Related]
3. Immediate radical resection after local excision of rectal cancer: an oncologic compromise? Hahnloser D; Wolff BG; Larson DW; Ping J; Nivatvongs S Dis Colon Rectum; 2005 Mar; 48(3):429-37. PubMed ID: 15747069 [TBL] [Abstract][Full Text] [Related]
4. Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial. Fujita S; Akasu T; Mizusawa J; Saito N; Kinugasa Y; Kanemitsu Y; Ohue M; Fujii S; Shiozawa M; Yamaguchi T; Moriya Y; Lancet Oncol; 2012 Jun; 13(6):616-21. PubMed ID: 22591948 [TBL] [Abstract][Full Text] [Related]
5. Is total mesorectal excision always necessary for T1-T2 lower rectal cancer? Kobayashi H; Mochizuki H; Kato T; Mori T; Kameoka S; Shirouzu K; Saito Y; Watanabe M; Morita T; Hida J; Ueno M; Ono M; Yasuno M; Sugihara K Ann Surg Oncol; 2010 Apr; 17(4):973-80. PubMed ID: 19953330 [TBL] [Abstract][Full Text] [Related]
6. Small carcinomas involving less than one-quarter of the rectal circumference: local excision is still associated with a high risk of nodal positivity. Ferko A; Orhalmi J; Dusek T; Chobola M; Hovorkova E; Hadzi Nikolov D; Dolejs J Colorectal Dis; 2015 Oct; 17(10):876-81. PubMed ID: 25808035 [TBL] [Abstract][Full Text] [Related]
7. Factors that influence the adequacy of total mesorectal excision for rectal cancer. Jeyarajah S; Sutton CD; Miller AS; Hemingway D; Colorectal Dis; 2007 Nov; 9(9):808-15. PubMed ID: 17441969 [TBL] [Abstract][Full Text] [Related]
8. Surgery for locally recurrent rectal cancer in the era of total mesorectal excision: is there still a chance for cure? Rahbari NN; Ulrich AB; Bruckner T; Münter M; Nickles A; Contin P; Löffler T; Reissfelder C; Koch M; Büchler MW; Weitz J Ann Surg; 2011 Mar; 253(3):522-33. PubMed ID: 21209587 [TBL] [Abstract][Full Text] [Related]
9. Survival outcome of local excision versus radical resection of colon or rectal carcinoma: a Surveillance, Epidemiology, and End Results (SEER) population-based study. Bhangu A; Brown G; Nicholls RJ; Wong J; Darzi A; Tekkis P Ann Surg; 2013 Oct; 258(4):563-9; discussion 569-71. PubMed ID: 23979270 [TBL] [Abstract][Full Text] [Related]
10. Comparative outcome between chemoradiotherapy and lateral pelvic lymph node dissection following total mesorectal excision in rectal cancer. Kim JC; Takahashi K; Yu CS; Kim HC; Kim TW; Ryu MH; Kim JH; Mori T Ann Surg; 2007 Nov; 246(5):754-62. PubMed ID: 17968166 [TBL] [Abstract][Full Text] [Related]
11. Predictors for regional lymph node metastasis in T1 rectal cancer: a population-based SEER analysis. Brunner W; Widmann B; Marti L; Tarantino I; Schmied BM; Warschkow R Surg Endosc; 2016 Oct; 30(10):4405-15. PubMed ID: 26895892 [TBL] [Abstract][Full Text] [Related]
12. Partial Mesorectal Excision for Rectal Adenocarcinoma: Morbidity and Oncological Outcome. Kanso F; Lefevre JH; Svrcek M; Chafai N; Parc Y; Tiret E Clin Colorectal Cancer; 2016 Mar; 15(1):82-90.e1. PubMed ID: 26372333 [TBL] [Abstract][Full Text] [Related]
13. Local excision of T1 and T2 rectal cancer: proceed with caution. Elmessiry MM; Van Koughnett JA; Maya A; DaSilva G; Wexner SD; Bejarano P; Berho M Colorectal Dis; 2014 Sep; 16(9):703-9. PubMed ID: 24787457 [TBL] [Abstract][Full Text] [Related]
14. [Lymph node metastases in ypT1/2 rectal cancer after neoadjuvant chemoradiotherapy : The Achilles heel of organ-preserving operative procedures?]. Sprenger T; Rothe H; Beissbarth T; Conradi LC; Kauffels A; Homayounfar K; Behnes CL; Rödel C; Liersch T; Ghadimi M Chirurg; 2016 Jul; 87(7):593-601. PubMed ID: 27106241 [TBL] [Abstract][Full Text] [Related]
15. Lymph node ratio and surgical quality are strong prognostic factors of rectal cancer: results from a single referral centre. Leonard D; Remue C; Abbes Orabi N; van Maanen A; Danse E; Dragean A; Debetancourt D; Humblet Y; Jouret-Mourin A; Maddalena F; Medina Benites A; Scalliet P; Sempoux C; Van den Eynde M; De Schoutheete JC; Kartheuser A Colorectal Dis; 2016 Jun; 18(6):O175-84. PubMed ID: 27128602 [TBL] [Abstract][Full Text] [Related]
16. Stage-Dependent Frequency of Lymph Node Metastases in Patients With Rectal Carcinoma After Preoperative Chemoradiation: Results from the CAO/ARO/AIO-94 Trial and From a Comparative Prospective Evaluation With Extensive Pathological Workup. Sprenger T; Rothe H; Conradi LC; Beissbarth T; Kauffels A; Kitz J; Homayounfar K; Wolff H; Ströbel P; Ghadimi M; Wittekind C; Sauer R; Rödel C; Liersch T Dis Colon Rectum; 2016 May; 59(5):377-85. PubMed ID: 27050599 [TBL] [Abstract][Full Text] [Related]
17. Endoscopic posterior mesorectal resection after transanal local excision of T1 carcinomas of the lower third of the rectum. Zerz A; Müller-Stich BP; Beck J; Linke GR; Tarantino I; Lange J Dis Colon Rectum; 2006 Jun; 49(6):919-24. PubMed ID: 16612534 [TBL] [Abstract][Full Text] [Related]
18. Is pre-operative radiotherapy necessary in T-T rectal cancer with TME? Mackay G; Downey M; Molloy RG; O'Dwyer PJ Colorectal Dis; 2006 Jan; 8(1):34-6. PubMed ID: 16519635 [TBL] [Abstract][Full Text] [Related]
19. Efforts to improve local control in rectal cancer compromise survival by the potential morbidity of optimal mesorectal excision. Laurent C; Nobili S; Rullier A; Vendrely V; Saric J; Rullier E J Am Coll Surg; 2006 Nov; 203(5):684-91. PubMed ID: 17084330 [TBL] [Abstract][Full Text] [Related]
20. Prediction of treatment outcome by CD44v6 after total mesorectal excision in locally advanced rectal cancer. Peng J; Lu JJ; Zhu J; Xu Y; Lu H; Lian P; Cai G; Cai S Cancer J; 2008; 14(1):54-61. PubMed ID: 18303484 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]